Vitamin B12 and folate: key predictors of HPV persistence in ASCUS patients

Kakoli Nikhil Banerjee; Poonam Rani; Mukul Chandra; Fayaz H. Khan; Saroj Singh

doi:10.18203/2320-1770.ijrcog20262519

Authors

Kakoli Nikhil Banerjee Department of Obstetrics and Gynecology, FH Medical College, Agra, Uttar Pradesh, India
Poonam Rani F.H. Medical College and Hospital, Agra
Mukul Chandra Department of Obstetrics and Gynecology, FH Medical College, Agra, Uttar Pradesh, India
Fayaz H. Khan Department of Obstetrics and Gynecology, FH Medical College, Agra, Uttar Pradesh, India
Saroj Singh Department of Obstetrics and Gynecology, FH Medical College, Agra, Uttar Pradesh, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20262519

Keywords:

Atypical squamous cells of undetermined significance, Folic acid, Papillomavirus infections, Uterine cervical neoplasms, Uterine cervical dysplasia, Vitamin B12

Abstract

Background: Persistent infection with high-risk human papillomavirus (HPV) is the key driver of cervical carcinogenesis. Atypical squamous cells of undetermined significance (ASCUS) represent an equivocal cytology category in which optimal triage is crucial. Disturbances in one-carbon metabolism, particularly low vitamin B12 and folate, may impair DNA repair and immune responses, favouring HPV persistence. This study aimed to evaluate serum vitamin B12 and folate levels in women with ASCUS compared with cytologically normal controls and to explore their association with HPV positivity in ASCUS.

Methods: This comparative cross-sectional study was conducted in the Department of Obstetrics and Gynaecology, FH Medical College, Agra. Fifty women were enrolled: 25 with ASCUS cytology and 25 age-matched controls with normal Pap smears. Socio-demographic and clinical data were recorded. Fasting serum vitamin B12 and folate were measured using an automated immunoassay. High-risk HPV status in the ASCUS group was determined by PCR. Group comparisons were performed using appropriate statistical tests and the association between micronutrient levels and HPV positivity was assessed.

Results: Women with ASCUS had significantly lower vitamin B12 (265.17±54.25 vs 315.26±65.62 pg/ml, p<0.01) and folate (9.53±1.76 vs 11.91±2.62 ng/ml, p<0.01) than controls. Within the ASCUS group, HPV-positive women showed markedly reduced vitamin B12 (200.14±12.47 vs 295.53±40.25 pg/ml, p<0.01) and folate (7.86±0.61 vs 10.23±1.59 ng/ml; p<0.01) compared with HPV-negative ASCUS patients. Lower micronutrient levels showed a clear inverse association with HPV positivity.

Conclusions: Women with ASCUS, particularly those who are HPV-positive, exhibit significant subclinical deficiencies of vitamin B12 and folate. These findings suggest that impaired one-carbon metabolism may contribute to HPV persistence at an early stage and that vitamin B12 and folate could serve as simple, adjunctive biomarkers to refine risk stratification and follow-up strategies in ASCUS patients.

References

Singh D, Vignat J, Lorenzoni V, Eslahi M, Ginsburg O, Lauby-Secretan B, et al. Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. Lancet Glob Health. 2023;11(2):197-206.

International Agency for Research on Cancer. GLOBOCAN 2020: India Fact Sheet. Lyon: IARC; 2021. Global Cancer Observatory; 2021.

Zhan X, Wang S, Wu X. Atypical squamous cells of undetermined significance. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023.

Cox JT. Management of atypical squamous cells of undetermined significance. J Low Genit Tract Dis. 2003;7(3):178-83.

Pathak S, Wilkhoo H, Mishra PK, Chander B, Mahajan VK, Sud R, et al. Cervical cancer pathogenesis is associated with one-carbon metabolism. Mol Cell Biochem. 2012;369(1-2):1-7.

Zhao W, Hao M, Wang Y, Feng N, Wang Z, Wang W, et al. Association between serum folate and cervical intraepithelial neoplasia and HPV infection in Chinese women: a case–control study. Nutrition. 2016;32(3):367-72.

Silva NNT, Gonçalves AK, Cobucci RN, Mendonça RC, Lima PH, Costa VV. Association of serum folate and vitamin B12 with pre-neoplastic cervical lesions. J Obstet Gynaecol. 2020;40(7):1001-6.

Yenigul NN, Yazıcı Yılmaz F, Ayhan I. Can serum vitamin B12 and folate levels predict HPV penetration in patients with ASCUS. Nutr Cancer. 2021;73(4):602-8.

Piyathilake CJ, Badiga S, Paul P, Vijayaraghavan K, Vedantham H, Sudula M, et al. Indian women with higher serum concentrations of folate and vitamin B12 are significantly less likely to be infected with carcinogenic or high-risk types of human papillomaviruses (HPVs). Int J Women Health. 2010;2:7-12.

Pathak S, Bajpai D, Banerjee A, Bhatla N, Jain SK, Jayaram HN, et al. Serum one-carbon metabolites and risk of cervical cancer. Nutr Cancer. 2014;66(5):818-24.

Yang J, Yang A, Wang Z, Wang W, Wang Z, Wang Y, et al. Interactions between serum folate and human papillomavirus with cervical intraepithelial neoplasia risk in a Chinese population-based study. Am J Clin Nutr. 2018;108(5):1034-42.

Ferrari FA, Magni F, Bosco M, Biancotto G, Zorzato PC, Laganà AS, et al. The role of micronutrients in human papillomavirus infection, cervical dysplasia and neoplasm. Healthcare (Basel). 2023;11(11):1652.

Sedjo RL, Fowler BM, Schneider A, Henning SM, Hatch K, Giuliano AR. Folate, vitamin B12 and homocysteine status: findings of no relation between human papillomavirus persistence and cervical dysplasia. Nutrition. 2003;19(6):497-502.

Alberg AJ, Selhub J, Shah KV, Viscidi RP, Comstock GW, Helzlsouer KJ. The risk of cervical cancer in relation to serum concentrations of folate, vitamin B12 and homocysteine. Cancer Epidemiol Biomarkers Prev. 2000;9(7):761-4.

Butterworth CE, Hatch KD, Macaluso M, Cole P, Sauberlich HE, Soong SJ, et al. Folate deficiency and cervical dysplasia. JAMA. 1992;267(4):528-33.